Metformin is the first-line first-line and full-course medication for the treatment of type 2 diabetes, mainly by increasing the sensitivity of muscles, fat and other peripheral tissues to in-sulin, increasing the uptake and utilization of glucose, promoting anaerobic glycolysis of sugar, and inhibiting liver gluconeogenesis. , Reduce liver glucose output, inhibit intestinal wall cells uptake of glucose and reduce fasting and postprandial hyperglycemia. In addition, metformin also has a weight loss effect, and can inhibit the biosynthesis and storage of cholesterol, reduce triglyceride and total cholesterol levels, improve the function of vascular endothelial cells, and increase blood flow. It is especially suitable for obese or overweight type 2 diabetic patients. Prevent the occurrence and development of diabetic macrovascular complications and reduce the incidence of cardiovascular events.
Product Name | Metformin |
CAS No. | 657-24-9 |
Purity | 99% |
Grade Standard | Medical Standard |
MF | C4H11N5 |
MW | 129.16 |
Test Method | HPLC |
Other Name | Metformin Powder |
Appearance | White Powder |
Brand | Fousi |